BioMall
Brand Store/BDB Bioscience/BD PhosflowTM Alexa Fluor 647 Mouse anti-p53 (acK382)
BD PhosflowTM Alexa Fluor 647 Mouse anti-p53 (acK382)
GENERAL CATALOGUE

BD PhosflowTM Alexa Fluor 647 Mouse anti-p53 (acK382)

560231 ·

BDB Bioscience · Cat: 560231

₹250 – ₹380 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 560231
Category: reagents
Brand: BDB Bioscience

Description

Analysis of p53 acK382 in lymphocytes. Human peripheral blood mononuclear cells PBMC were either treated with 0.4 muM Trichostatin A Sigma, Cat. No. T8552 plus 0.4 muM Adriamycin Doxorubicin hydrochloride, Sigma, Cat. No. D1515 for 24 hours shaded histogram or untreated open histogram . The cells were fixed BD Cytofix buffer, Cat. No. 554655 for 10 minutes, then permeabilized BD Phosflow Perm Buffer III, Cat. No. 558050 on ice for at least 30 minutes, and then stained with Alexa Fluor 647 Mouse anti-p53 acK382 . Lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSArray bioanalyzer system. The specificity of mAb L82-51 was confirmed by western blot analysis using unconjugated antibody on lysates from control left blot and Trichostatin A-plus-Adriamycin-treated right blot PBMC. p53 acK382 is identified as a band of 53 kDa in the treated cells. Analysis of p53 acK382 in lymphocytes. Human peripheral blood mononuclear cells PBMC were either treated with 0.4 muM Trichostatin A Sigma, Cat. No. T8552 plus 0.4 muM Adriamycin Doxorubicin hydrochloride, Sigma, Cat. No. D1515 for 24 hours shaded histogram or untreated open histogram . The cells were fixed BD Cytofix buffer, Cat. No. 554655 for 10 minutes, then permeabilized BD Phosflow Perm Buffer III, Cat. No. 558050 on ice for at least 30 minutes, and then stained with Alexa Fluor 647 Mouse anti-p53 acK382 . Lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSArray bioanalyzer system. The specificity of mAb L82-51 was confirmed by western blot analysis using unconjugated antibody on lysates from control left blot and Trichostatin A-plus-Adriamycin-treated right blot PBMC. p53 acK382 is identified as a band of 53 kDa in the treated cells. Show More Analysis of p53 acK382 in lymphocytes. Human peripheral blood mononuclear cells PBMC were either treated with 0.4 muM Trichostatin A Sigma, Cat. No. T8552 plus 0.4 muM Adriamycin Doxorubicin hydrochloride, Sigma, Cat. No. D1515 for 24 hours shaded histogram or untreated open histogram . The cells were fixed BD Cytofix buffer, Cat. No. 554655 for 10 minutes, then permeabilized BD Phosflow Perm Buffer III, Cat. No. 558050 on ice for at least 30 minutes, and then stained with Alexa Fluor 647 Mouse anti-p53 acK382 . Lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSArray bioanalyzer system. The specificity of mAb L82-51 was confirmed by western blot analysis using unconjugated antibody on lysates from control left blot and Trichostatin A-plus-Adriamycin-treated right blot PBMC. p53 acK382 is identified as a band of 53 kDa in the treated cells.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents